310 related articles for article (PubMed ID: 19326637)
1. Torsade de pointes following intravenous haloperidol administration in a patient with complete heart block.
Ginwalla M; Biblo LA; Paydak H
WMJ; 2009 Feb; 108(1):48-50. PubMed ID: 19326637
[TBL] [Abstract][Full Text] [Related]
2. Accuracy of uncorrected versus corrected QT interval for prediction of torsade de pointes associated with intravenous haloperidol.
Tisdale JE; Kovacs R; Mi D; McCabe GP; Cariera BL; Sharma N; Rosman H
Pharmacotherapy; 2007 Feb; 27(2):175-82. PubMed ID: 17253907
[TBL] [Abstract][Full Text] [Related]
3. Torsade de pointes and low-dose oral haloperidol.
Jackson T; Ditmanson L; Phibbs B
Arch Intern Med; 1997 Sep; 157(17):2013-5. PubMed ID: 9308514
[TBL] [Abstract][Full Text] [Related]
4. A case series of drug-induced long QT syndrome and Torsade de Pointes.
Tong KL; Lau YS; Teo WS
Singapore Med J; 2001 Dec; 42(12):566-70. PubMed ID: 11989578
[TBL] [Abstract][Full Text] [Related]
5. Torsade de pointes due to noncardiac drugs: most patients have easily identifiable risk factors.
Zeltser D; Justo D; Halkin A; Prokhorov V; Heller K; Viskin S
Medicine (Baltimore); 2003 Jul; 82(4):282-90. PubMed ID: 12861106
[TBL] [Abstract][Full Text] [Related]
6. Torsade de pointes induced by psychotropic drugs and the prevalence of its risk factors.
Justo D; Prokhorov V; Heller K; Zeltser D
Acta Psychiatr Scand; 2005 Mar; 111(3):171-6. PubMed ID: 15701100
[TBL] [Abstract][Full Text] [Related]
7. Increased short-term variability of repolarization predicts d-sotalol-induced torsades de pointes in dogs.
Thomsen MB; Verduyn SC; Stengl M; Beekman JD; de Pater G; van Opstal J; Volders PG; Vos MA
Circulation; 2004 Oct; 110(16):2453-9. PubMed ID: 15477402
[TBL] [Abstract][Full Text] [Related]
8. Haloperidol-induced torsade de pointes.
O'Brien JM; Rockwood RP; Suh KI
Ann Pharmacother; 1999 Oct; 33(10):1046-50. PubMed ID: 10534216
[TBL] [Abstract][Full Text] [Related]
9. Drug-induced block of cardiac HERG potassium channels and development of torsade de pointes arrhythmias: the case of antipsychotics.
Calderone V; Testai L; Martinotti E; Del Tacca M; Breschi MC
J Pharm Pharmacol; 2005 Feb; 57(2):151-61. PubMed ID: 15720777
[TBL] [Abstract][Full Text] [Related]
10. Torsades de pointes secondary to intravenous haloperidol after coronary bypass grafting surgery.
Perrault LP; Denault AY; Carrier M; Cartier R; Bélisle S
Can J Anaesth; 2000 Mar; 47(3):251-4. PubMed ID: 10730737
[TBL] [Abstract][Full Text] [Related]
11. Drug-induced long QT syndrome and torsade de pointes.
Morissette P; Hreiche R; Turgeon J
Can J Cardiol; 2005 Aug; 21(10):857-64. PubMed ID: 16107909
[TBL] [Abstract][Full Text] [Related]
12. Torsade de pointes in a patient with complex medical and psychiatric conditions receiving low-dose quetiapine.
Vieweg WV; Schneider RK; Wood MA
Acta Psychiatr Scand; 2005 Oct; 112(4):318-22; author reply 322. PubMed ID: 16156840
[TBL] [Abstract][Full Text] [Related]
13. Acquired long QT syndrome: risperidone-facilitated triggered activity and Torsades de Pointes during complete AV block. I.
Raviña T; Raviña P; Gutierrez J
Int J Cardiol; 2007 Apr; 116(3):416-20. PubMed ID: 16875747
[TBL] [Abstract][Full Text] [Related]
14. Torsade de pointes, acquired complete heart block and inappropriately long QT in childhood.
Gladman G; Davis AM; Fogelman R; Hamilton RM; Gow RM
Can J Cardiol; 1996 Jul; 12(7):683-5. PubMed ID: 8689540
[TBL] [Abstract][Full Text] [Related]
15. Torsade de pointes associated with the administration of intravenous haloperidol:a review of the literature and practical guidelines for use.
Hassaballa HA; Balk RA
Expert Opin Drug Saf; 2003 Nov; 2(6):543-7. PubMed ID: 14585064
[TBL] [Abstract][Full Text] [Related]
16. Conduction disturbances associated with administration of butyrophenone antipsychotics in the critically ill: a review of the literature.
Lawrence KR; Nasraway SA
Pharmacotherapy; 1997; 17(3):531-7. PubMed ID: 9165555
[TBL] [Abstract][Full Text] [Related]
17. QT interval prolongation, torsade de pointes and renal disease.
Patanè S; Marte F; Di Bella G; Currò A; Coglitore S
Int J Cardiol; 2008 Nov; 130(2):e71-3. PubMed ID: 18255176
[TBL] [Abstract][Full Text] [Related]
18. Assessment of Safety Margin of an Antipsychotic Drug Haloperidol for Torsade de Pointes Using the Chronic Atrioventricular Block Dogs.
Izumi-Nakaseko H; Nakamura Y; Cao X; Wada T; Ando K; Sugiyama A
Cardiovasc Toxicol; 2017 Jul; 17(3):319-325. PubMed ID: 27738880
[TBL] [Abstract][Full Text] [Related]
19. Methadone-induced torsade de pointes in a patient with normal baseline QT interval.
Almehmi A; Malas AM; Yousufuddin M; Rosencrance JG
W V Med J; 2004; 100(4):147-8. PubMed ID: 15471174
[TBL] [Abstract][Full Text] [Related]
20. Drug-induced long QT and torsade de pointes: recent advances.
Kannankeril PJ; Roden DM
Curr Opin Cardiol; 2007 Jan; 22(1):39-43. PubMed ID: 17143043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
